New Insights in Cardiac Ischemic Diseases

Dear Colleagues, 

Cardiac ischemic diseases are the most common causes of death worldwide. Ischemia-Reperfusion (I/R) process leads to O₂, metabolic and redox homeostasis alterations inducing tissue critical damages and/or contributing to the remodeling process as well as cardiac function alteration. Indeed, I/R triggers acute or chronic deleterious processes such as oxidative stress, inflammation, sympathetic nervous system activation, endoplasmic reticulum stress, mitochondrial function and dynamic alteration. In recent decades, we have advanced in our understanding of the biological and molecular pathways at the crosstalk of O₂ and metabolic homeostasis. More especially, the role of transcriptional activity (i.e., Hypoxia Inducible Factor-1, Nuclear factor-erythroid Factor 2-Related factor 2…) and post-translational modifications (i.e., phosphorylation, acetylation, citrullination, O-GlcNAcylation, Prolyl hydroxylation…) seems to represent innovative targets influencing I/R effects. Nevertheless, pre-clinical or clinical approaches addressing these issues are missing to improve our knowledge to explain deleterious consequences of I/R.

Thus, this Special Issue is dedicated to highlighting new pathways that contribute to the development of cardiac ischemic diseases. We aim to be able to bring a better knowledge for long-term efficient management of the disease. We invite investigators to present recent advances in the comprehension of the molecular pathways leading to acute and chronic response to I/R as well as the development of new approaches to prevent adverse consequences of I/R.

Dr. Delphine Baetz
Dr. Elise Belaïdi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• cardiac ischemic diseases
• ischemia-reperfusion
• cardiac remodeling and function
• transcriptional activity and post-translational modifications
• ischemic heart disease
• heart failure